Intranasal administration of IL-13 after tMCAO attenuated sensorimotor and cognitive deficits, which correlated with a decrease in white matter damage, lending further support that loss of white matter integrity is strongly linked to poor stroke outcomes in ischemic stroke patients [33]. The gene discussed is IL13; the disease is ischemic stroke.